Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cencora, Inc. (COR : NYSE)

• Company Description    CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. Number of Employees: 51,000

• Price / Volume Information    Yesterday's Closing Price: $337.75 Daily Weekly Monthly 20 Day Moving Average: 1,175,486 shares Shares Outstanding: 193.99 (millions) Market Capitalization: $65,521.29 (millions) Beta: 0.66 52 Week High: $377.54 52 Week Low: $225.75 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.04% 0.21% 12 Week 7.52% 5.79% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 West First Avenue - Conshohocken,PA 19428 USA ph: 610-727-7000 fax: 800-640-5221 investorrelations@cencora.com http://www.cencora.com

• General Corporate Information    Officers Robert P. Mauch - Chief Executive Officer;President and Director D. Mark Durcan - Chairman and Director James F. Cleary - Executive Vice President and Chief Financial Offic Lazarus Krikorian - Senior Vice President and Chief Accounting Officer Werner Baumann - Director Peer Information Cencora, Inc. (CHCR) Cencora, Inc. (ESRX) Cencora, Inc. (MYDP) Cencora, Inc. (COR) Cencora, Inc. (GBCS) Cencora, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 03073E105 SIC: 5122 Fiscal Year Fiscal Year End: September Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/04/26 Share - Related Items Shares Outstanding: 193.99 Most Recent Split Date: 6.00 (2.00:1) Beta: 0.66 Market Capitalization: $65,521.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.71% Current Fiscal Quarter EPS Consensus Estimate: $4.88 Indicated Annual Dividend: $2.40 Current Fiscal Year EPS Consensus Estimate: $17.62 Payout Ratio: 0.14 Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: -0.03 Estmated Long-Term EPS Growth Rate: 11.93% Last Dividend Paid: 11/14/2025 - $0.60 Next EPS Report Date: 02/04/26

• Fundamental Ratios P/E Current FY Estimate: 19.17 Trailing 12 Months: 21.12 PEG Ratio: 1.61 Price Ratios Price/Book: 37.49 Price/Cash Flow: 15.63 Price / Sales: 0.20 EPS Growth vs. Year Ago Period: 14.97% vs. Previous Quarter: -4.00% Sales Growth vs. Year Ago Period: 5.92% vs. Previous Quarter: 3.80% ROE 12/31/25 - - 09/30/25 - 227.15 06/30/25 - 267.36 ROA 12/31/25 - - 09/30/25 - 4.30 06/30/25 - 4.31 Current Ratio 12/31/25 - - 09/30/25 - 0.90 06/30/25 - 0.90 Quick Ratio 12/31/25 - - 09/30/25 - 0.55 06/30/25 - 0.53 Operating Margin 12/31/25 - - 09/30/25 - 0.97 06/30/25 - 0.96 Net Margin 12/31/25 - - 09/30/25 - 0.48 06/30/25 - 0.60 Pre-Tax Margin 12/31/25 - - 09/30/25 - 0.70 06/30/25 - 0.81 Book Value 12/31/25 - - 09/30/25 - 9.01 06/30/25 - 11.40 Inventory Turnover 12/31/25 - - 09/30/25 - 15.47 06/30/25 - 15.55 Debt-to-Equity 12/31/25 - - 09/30/25 - 4.32 06/30/25 - 3.64 Debt-to-Capital 12/31/25 - - 09/30/25 - 81.19 06/30/25 - 78.45

Powered by Zacks Investment Research ©